Dr. Paul Rousseau from Arizona State University has written an interesting summary of the problem of denial of terminal illness, published in the Journal of Clinical Oncology, May, 2003.
Below are selections from the article, which should pique one’s curiosity:
“Although denial may produce a focus of concern, it may also serve as a protective and adaptive mechanism to absorb deleterious and life-threatening information in a manageable and self-determined time frame.”
“If denial is determined to be present but not impacting the patient’s ability and desire to seek and accept help and is primarily an adaptive mechanism, it may be temporarily or permanently ignored.”
“Denial can reduce emotional distress and permit time for patients to absorb the consequences of a life-threatening illness while completing unfinished life work.”
Considering both harmless and harmful denial, he also relates strategies to help the patient suffering from so much denial that it “interferes with daily life and medical therapy.”
Update: it looks like the JCO won’t allow links to this article – my apologies. For those readers who tend to haunt medical libraries, the essay can be found in the Journal of Clinical Oncology, volume 21, pages 52-53, May 2003. I think I’m in denial over my webmaster skills…
Related posts:
- Did Facebook lead to health insurance denial?
- Patchwork cancer care
- Get your forced rectal coverage here
- The irony of Ted Kennedy and universal healthcare
- Implantable sensors
- Tips for suing
- Smokers in denial
{ 2 comments }
I heard that Lilly did a clinical trial for Zyprexa and they found that in the higher doses for use in schizophrenic patients that Zyprexa caused heart disease. I also heard they buried the research. Is this true? Or am I just getting paranoid and should my dose be increased?
I heard this from a nurse at the hospital I go to in Indianapolis.
i heard the same thing….
Comments on this entry are closed.